Skip to main content
Pharmsville Co., Ltd. logo

Pharmsville Co., Ltd. — Investor Relations & Filings

Ticker · 318010 ISIN · KR7318010006 KO Manufacturing
Open in API
Filings indexed 129 across all filing types
Latest filing 2024-03-18 Transaction in Own Shar…
Country KR South Korea
Listing KO 318010

About Pharmsville Co., Ltd.

http://pharmsville.net/

Pharmsville Co., Ltd. is a bio-healthcare company that develops, produces, and sells health functional foods and natural supplements. Founded in 2000, the company focuses on extending human healthspan through the research and development of novel ingredients, with a specialization in microbiome-based probiotics. Its product portfolio is marketed to both domestic and international consumers under brands such as 'Appletree Dr.'. The company supports its innovation through dedicated research facilities, including the Pharmsville Bio Lab, aiming to create health products that are as natural as possible for the human body.

Recent filings

Filing Released Lang Actions
신탁계약해지결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Trust Contract Termination Result Report' (신탁계약해지결과보고서) filed by Pharmsville with the Financial Supervisory Service (FSS) of South Korea. It details the termination of a stock repurchase trust contract and the subsequent transfer of shares to the company's own account. This falls under the category of 'Transaction in Own Shares' (POS) as it reports the conclusion of a share buyback program and the resulting status of treasury shares.
2024-03-18 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Pharmsville. It contains the meeting agenda, details on voting procedures, director activity reports, and financial statements (balance sheet and income statement) for the 24th fiscal year. This type of document is standard for proxy solicitation and shareholder meeting materials, which falls under the 'Proxy Solicitation & Information Statement' category.
2024-03-14 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company 'Farmsville'. It outlines the date, location, and agenda items (such as financial statement approval and director compensation). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2024-03-13 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company scheduled its AGM on a date that coincides with other companies, as identified by the KOSDAQ Association. Since this is a regulatory disclosure regarding meeting logistics rather than the AGM presentation materials themselves, and it does not fit into specific categories like proxy solicitation or voting results, it is classified as a general regulatory filing.
2024-03-13 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from the company '팜스빌' (Pharmsville) regarding the decision to pay cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the expected approval date at the upcoming general meeting of shareholders. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2024-03-13 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on Acquisition Status by Trust Agreement' (신탁계약등에의한취득상황보고서) filed by the company 'Pharmsville' with the Financial Supervisory Service. It details the specific daily transactions of the company buying back its own shares through a trust agreement with Daishin Securities. This type of filing is a standard regulatory disclosure for share buyback programs, which falls under the 'Transaction in Own Shares' category.
2023-12-19 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.